Leading in biological R&D
Intervet/Schering-Plough Animal Health invests a substantial part of its total annual sales in R&D. We have a network of R&D facilities worldwide, with Boxmeer being the largest for biological R&D – not only within Intervet/Schering-Plough Animal Health, but in the entire Dutch pharmaceutical industry.

A dynamic workplace
Boxmeer is home to Intervet/Schering-Plough Animal Health’s R&D departments for bacteriology, virology, parasitology and vaccine technology & immunology. It is a dynamic working environment, with a rapid succession of developments – developments that we regularly contribute towards. For example, Intervet/Schering-Plough Animal Health was the first company in the world to manufacture and market an inactivated vaccine with genetically modified organisms. Intervet/Schering-Plough Animal Health was also the first to bring a live bacterial GMO vaccine onto the European market.

Biotechnology of a high standard
Our expertise in biotechnology has led to the development of modern vaccine types such as sub-unit vaccines or vector vaccines for different types of micro-organisms and very advanced cell cultivation systems for vaccine production. Micro-arrays, bio-informatics and reverse genomics are also being increasingly used for the unraveling of host-pathogen interactions, (bio)process optimization and the selection of potential vaccine components.

Specialists in a multidisciplinary team
As an R&D worker at Intervet/Schering-Plough Animal Health, you are a specialist in a multidisciplinary team. You bring your expertise and creativity to vaccine projects in which experts from other fields are also involved, including molecular biology, (bio)process technology, biochemistry, vaccine technology, microbiology, pathology and veterinary science. In addition, you work together with professionals from such departments as Registration, Marketing, Quality Control, Production and Pathology. The collaboration between all these specialists ensures an unprecedented synergy that is inspiring for you and good for the company.

Want to contribute to developments in vaccine technology?
Our employees are up to speed with the latest developments in vaccine technology and have the creativity to apply that knowledge within the existing regulations. They are grounded in (medical) biology, (bio)chemistry, veterinary science, pharmaceutics, (bio)process technology, molecular biology or a similar study. Would you also like to work in a dynamic biotech environment and contribute to the high-speed developments occurring in vaccine technology? We are regularly on the lookout for university and higher professional graduates to bolster our R&D teams.